Susquehanna International Group’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.4M Sell
173,630
-14,946
-8% -$2.3M ﹤0.01% 1796
2025
Q4
$32.8M Sell
188,576
-44,530
-19% -$8.13M ﹤0.01% 1738
2025
Q3
$33.6M Buy
233,106
+20,884
+10% +$2.56M ﹤0.01% 1683
2025
Q2
$21.4M Sell
212,222
-236,392
-53% -$18.1M ﹤0.01% 1930
2025
Q1
$34.2M Buy
448,614
+4,179
+0.9% +$320K 0.01% 1277
2024
Q4
$30.7M Buy
444,435
+182,889
+70% +$13.2M ﹤0.01% 1511
2024
Q3
$19.1M Buy
261,546
+110,522
+73% +$8.16M ﹤0.01% 1878
2024
Q2
$10.1M Buy
151,024
+5,526
+4% +$214K ﹤0.01% 2465
2024
Q1
$3.95M Buy
145,498
+29,052
+25% +$813K ﹤0.01% 4036
2023
Q4
$3.61M Sell
116,446
-137,396
-54% -$3.56M ﹤0.01% 4277
2023
Q3
$6.41M Sell
253,842
-2,463
-1% -$56.3K ﹤0.01% 3146
2023
Q2
$5.41M Sell
256,305
-59,101
-19% -$1.12M ﹤0.01% 3388
2023
Q1
$5.38M Buy
315,406
+278,240
+749% +$5.41M ﹤0.01% 3361
2022
Q4
$743K Sell
37,166
-140,319
-79% -$2.71M ﹤0.01% 6867
2022
Q3
$3.82M Buy
177,485
+121,356
+216% +$2.91M ﹤0.01% 3601
2022
Q2
$1.11M Sell
56,129
-22,954
-29% -$481K ﹤0.01% 6277
2022
Q1
$1.86M Sell
79,083
-6,172
-7% -$143K ﹤0.01% 5646
2021
Q4
$2.32M Buy
85,255
+6,983
+9% +$200K ﹤0.01% 5158
2021
Q3
$2.16M Buy
78,272
+32,397
+71% +$850K ﹤0.01% 5663
2021
Q2
$1.31M Buy
45,875
+19,653
+75% +$583K ﹤0.01% 7020
2021
Q1
$893K Sell
26,222
-6,167
-19% -$236K ﹤0.01% 8028
2020
Q4
$1.08M Sell
32,389
-423
-1% -$15.5K ﹤0.01% 6550
2020
Q3
$1.05M Buy
32,812
+1,569
+5% +$45.1K ﹤0.01% 5992
2020
Q2
$861K Sell
31,243
-43,303
-58% -$1.03M ﹤0.01% 6238
2020
Q1
$1.2M Sell
74,546
-50,473
-40% -$1.2M ﹤0.01% 4981
2019
Q4
$2.98M Sell
125,019
-50,124
-29% -$1.02M ﹤0.01% 3707
2019
Q3
$3.09M Buy
175,143
+54,109
+45% +$1.04M ﹤0.01% 3436
2019
Q2
$3.1M Buy
+121,034
New +$3.37M ﹤0.01% 3397
2017
Q1
Sell
-115,572
Closed -$1.78M 9419
2016
Q4
$1.53M Buy
+115,572
New +$1.58M ﹤0.01% 4624
2016
Q3
Sell
-63,305
Closed -$792K 8705
2016
Q2
$624K Buy
63,305
+14,658
+30% +$171K ﹤0.01% 5754
2016
Q1
$616K Buy
48,647
+38,231
+367% +$503K ﹤0.01% 6029
2015
Q4
$189K Sell
10,416
-20,207
-66% -$356K ﹤0.01% 8475
2015
Q3
$569K Sell
30,623
-444
-1% -$11.1K ﹤0.01% 6869
2015
Q2
$759K Buy
+31,067
New +$705K ﹤0.01% 6775
2015
Q1
Sell
-51,563
Closed -$908K 9640
2014
Q4
$798K Buy
51,563
+38,641
+299% +$548K ﹤0.01% 6309
2014
Q3
$169K Sell
12,922
-14,771
-53% -$223K ﹤0.01% 8812
2014
Q2
$553K Sell
27,693
-152,747
-85% -$2.26M ﹤0.01% 7275
2014
Q1
$3.44M Buy
180,440
+167,272
+1,270% +$3.18M ﹤0.01% 3429
2013
Q4
$224K Sell
13,168
-146
-1% -$2.24K ﹤0.01% 8064
2013
Q3
$208K Buy
+13,314
New +$169K ﹤0.01% 7720

Other funds holding INSM

Susquehanna International Group's INSM Position: Q1 2026 in Review

Susquehanna International Group reduced its Insmed (INSM) stake by 7.9% in Q1 2026, selling an estimated $2.3M and leaving 173,630 shares worth $28.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1796.

Susquehanna International Group first reported a position in INSM in Q3 2013 and has held it in 40 quarters since. The position peaked at $34.2M in Q1 2025. 672 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Susquehanna International Group held 173,630 shares of Insmed worth $28.4M as of Q1 2026.
  • Susquehanna International Group sold 14,946 Insmed shares in Q1 2026, an estimated $2.3M.
  • Insmed made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1796 holding.
  • Susquehanna International Group first reported a position in Insmed in Q3 2013 and has held it in 40 quarters since.
  • Susquehanna International Group's Insmed position peaked at $34.2M in Q1 2025.
  • 672 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.